About IGEA
IGEA is a company based in Carpi (Italy) founded in 1980.. IGEA has raised $3.93 million across 2 funding rounds from investors including European Union and Innogest Capital. IGEA offers products and services including Biostim ®, Cliniporator ®, and I-ONE ®. IGEA operates in a competitive market with competitors including Globus Medical, RTI Surgical, Implanet, DJO Global and OMNILife Sciences, among others.
- Headquarter Carpi, Italy
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Igea S.P.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.93 M (USD)
in 2 rounds
-
Latest Funding Round
$219.06 K (USD), Grant
Apr 01, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IGEA
IGEA offers a comprehensive portfolio of products and services, including Biostim ®, Cliniporator ®, and I-ONE ®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Promotes healing of bone fractures and joint conditions.
Treats tumours using electroporation technology.
Supports therapy for spinal and bone-related issues.
Funding Insights of IGEA
IGEA has successfully raised a total of $3.93M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $219.06 thousand completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $219,059
-
First Round
First Round
(24 Dec 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Grant - IGEA | Valuation |
investors |
|
| Dec, 2010 | Amount | Series A - IGEA | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IGEA
IGEA has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Innogest Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in seed and early stage companies in Italy
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IGEA
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IGEA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Igea Comparisons
Competitors of IGEA
IGEA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Globus Medical, RTI Surgical, Implanet, DJO Global and OMNILife Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of minimally invasive products for musculoskeletal procedures
|
|
| domain | founded_year | HQ Location |
Develops innovative technologies for spinal and orthopedic implants and instruments.
|
|
| domain | founded_year | HQ Location |
Orthopedic implants are developed for spine, knee, and arthroscopy procedures.
|
|
| domain | founded_year | HQ Location |
Orthopedic devices and pain management products are developed.
|
|
| domain | founded_year | HQ Location |
Hip and knee orthopedic implants are engineered, manufactured, and distributed.
|
|
| domain | founded_year | HQ Location |
Orthopedic implants and surgical instruments are manufactured for joint surgeries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about IGEA
When was IGEA founded?
IGEA was founded in 1980 and raised its 1st funding round 30 years after it was founded.
Where is IGEA located?
IGEA is headquartered in Carpi, Italy. It is registered at Carpi, Emilia-romagna, Italy.
Is IGEA a funded company?
IGEA is a funded company, having raised a total of $3.93M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.93M, raised on Dec 24, 2010.
What does IGEA do?
IGEA develops orthopedic medical devices to promote reparative osteogenesis and joint protection, and oncological biophysics for the treatment of solid tumors. It develops orthopedic solutions for the treatment of post-traumatic bone disorders and cartilage lesions by using non-ionizing physical energy; and oncology solutions for the treatment of solid tumors using electro-chemotherapy. The companys orthopedic products include BioStim, a bone growth stimulator to activate and enhance bone healing, OsteoBit, a device using electrical fields for bone growth stimulation, OsteoSpine, a medical device for the treatment of chronic pain in patients suffering from vertebral osteoporotic fractures, and Fast, an ultrasound medical device for the treatment of recent fractures and non-unions and I-ONE therapy, a local treatment to prevent cartilage degeneration. Its oncology products include Cliniporator, a medical device for the electroporation of tumor nodules in outpatient clinics.
Who are the top competitors of IGEA?
IGEA's top competitors include Globus Medical, ExacTech and Implanet.
What products or services does IGEA offer?
IGEA offers Biostim ®, Cliniporator ®, and I-ONE ®.
Who are IGEA's investors?
IGEA has 2 investors. Key investors include European Union, and Innogest Capital.